| scholarly article | Q13442814 |
| P50 | author | Stephen J. O'Brien | Q7609573 |
| John R. Mascola | Q63302442 | ||
| P2093 | author name string | D R Littman | |
| G Chang | |||
| G C White | |||
| B Volsky | |||
| V N KewalRamani | |||
| J A Nelson | |||
| R Swanstrom | |||
| N L Michael | |||
| T R O'Brien | |||
| M Louder | |||
| P2860 | cites work | Macrophage-tropic variants initiate human immunodeficiency virus type 1 infection after sexual, parenteral, and vertical transmission | Q22241902 |
| Genotypic and phenotypic characterization of HIV-1 patients with primary infection | Q22242245 | ||
| HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor | Q22242268 | ||
| Mt-2 Cell Tropism Of Human Immunodeficiency Virus Type 1 Isolates As A Marker For Response To Treatment And Development Of Drug Resistance | Q22242877 | ||
| Identification of a major co-receptor for primary isolates of HIV-1 | Q22251282 | ||
| Molecular cloning and functional expression of a new human CC-chemokine receptor gene | Q24313022 | ||
| Role of CCR5 in infection of primary macrophages and lymphocytes by macrophage-tropic strains of human immunodeficiency virus: resistance to patient-derived and prototype isolates resulting from the delta ccr5 mutation | Q39382962 | ||
| The characterization of non-progressors: long-term HIV-1 infection with stable CD4+ T-cell levels. | Q41531784 | ||
| Prognostic value of HIV-1 syncytium-inducing phenotype for rate of CD4+ cell depletion and progression to AIDS. | Q41557849 | ||
| Characterization of an HIV-1 Isolate Displaying an Apparent Absence of Virion-Associated Reverse Transcriptase Activity | Q41691433 | ||
| The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. | Q43521980 | ||
| 32 bp CCR-5 gene deletion and resistance to fast progression in HIV-1 infected heterozygotes | Q44088122 | ||
| The natural history of HIV-1 infection: virus load and virus phenotype independent determinants of clinical course? | Q45783098 | ||
| Risk of human immunodeficiency virus (HIV-1) infection among laboratory workers | Q45832455 | ||
| Multiple extracellular elements of CCR5 and HIV-1 entry: dissociation from response to chemokines | Q46722581 | ||
| HIV-1 proviral genotypes from the peripheral blood mononuclear cells of an infected patient are differentially represented in expressed sequences. | Q48100064 | ||
| A new SIV co-receptor, STRL33. | Q55067123 | ||
| Dual infection of the central nervous system by AIDS viruses with distinct cellular tropisms. | Q55487007 | ||
| Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the CKR5 Structural Gene | Q56591978 | ||
| HIV-1 infection in a man homozygous for CCR5▵32 | Q58277776 | ||
| Heterozygosity for a deletion in the CKR-5 gene leads to prolonged AIDS-free survival and slower CD4 T-cell decline in a cohort of HIV-seropositive individuals | Q59297255 | ||
| Improved direct PCR screen for bacterial colonies: wooden toothpicks inhibit PCR amplification | Q71689870 | ||
| HIV-1 infection in an individual homozygous for the CCR5 deletion allele | Q73122336 | ||
| HIV-1 infection in an individual homozygous for CCR5 delta 32. Seroco Study Group | Q73296691 | ||
| Association between CCR5 genotype and the clinical course of HIV-1 infection | Q73907325 | ||
| The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry | Q24315492 | ||
| Expression cloning of new receptors used by simian and human immunodeficiency viruses | Q24318669 | ||
| Molecular cloning and functional characterization of a novel human CC chemokine receptor (CCR5) for RANTES, MIP-1beta, and MIP-1alpha | Q24321555 | ||
| Two orphan seven-transmembrane segment receptors which are expressed in CD4-positive cells support simian immunodeficiency virus infection | Q24652969 | ||
| Inherited resistance to HIV-1 conferred by an inactivating mutation in CC chemokine receptor 5: studies in populations with contrasting clinical phenotypes, defined racial background, and quantified risk | Q24654734 | ||
| High-efficiency transformation of mammalian cells by plasmid DNA | Q27860469 | ||
| A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors | Q28118386 | ||
| The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus | Q28259668 | ||
| Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells | Q28270680 | ||
| The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates | Q28282895 | ||
| CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia | Q28303212 | ||
| T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV | Q28646817 | ||
| CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1 | Q28646859 | ||
| Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line | Q29547239 | ||
| Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone | Q29547734 | ||
| Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene | Q29614892 | ||
| Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection | Q29614956 | ||
| The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1 | Q29616093 | ||
| HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5 | Q29616094 | ||
| The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain | Q29618472 | ||
| The role of mononuclear phagocytes in HTLV-III/LAV infection | Q29618676 | ||
| Global distribution of the CCR5 gene 32-basepair deletion. | Q34425080 | ||
| In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression. | Q34445208 | ||
| Growth of macrophage-tropic and primary human immunodeficiency virus type 1 (HIV-1) isolates in a unique CD4+ T-cell clone (PM1): failure to downregulate CD4 and to interfere with cell-line-tropic HIV-1. | Q35839936 | ||
| A seven-transmembrane domain receptor involved in fusion and entry of T-cell-tropic human immunodeficiency virus type 1 strains. | Q35868457 | ||
| Evolutionary variants of the human immunodeficiency virus type 1 V3 region characterized by using a heteroduplex tracking assay | Q35898952 | ||
| CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro | Q36377185 | ||
| Complete nucleotide sequence, genome organization, and biological properties of human immunodeficiency virus type 1 in vivo: evidence for limited defectiveness and complementation | Q36685254 | ||
| Molecular uncoupling of C-C chemokine receptor 5-induced chemotaxis and signal transduction from HIV-1 coreceptor activity | Q36765049 | ||
| Standardized microtiter assay for determination of syncytium-inducing phenotypes of clinical human immunodeficiency virus type 1 isolates. | Q37091757 | ||
| Sensitivity to inhibition by beta-chemokines correlates with biological phenotypes of primary HIV-1 isolates | Q37094738 | ||
| Homozygous delta 32 deletion of the CCR-5 chemokine receptor gene in an HIV-1-infected patient. | Q38890421 | ||
| The V3 domain of the HIV-1 gp120 envelope glycoprotein is critical for chemokine-mediated blockade of infection | Q38949380 | ||
| HIV-1 entry and macrophage inflammatory protein-1beta-mediated signaling are independent functions of the chemokine receptor CCR5. | Q39000361 | ||
| The role of viral phenotype and CCR-5 gene defects in HIV-1 transmission and disease progression | Q39249450 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | homozygosity | Q114049690 |
| P304 | page(s) | 6040-6047 | |
| P577 | publication date | 1998-07-01 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Exclusive and persistent use of the entry coreceptor CXCR4 by human immunodeficiency virus type 1 from a subject homozygous for CCR5 delta32 | |
| P478 | volume | 72 |
| Q39156048 | A Review of Functional Motifs Utilized by Viruses. |
| Q34333673 | A human immunodeficiency virus type 1 isolate from an infected person homozygous for CCR5Delta32 exhibits dual tropism by infecting macrophages and MT2 cells via CXCR4. |
| Q34089069 | A novel CXCR4-selective high-affinity fluorescent probe and its application in competitive binding assays |
| Q33825328 | A polymorphism in the regulatory region of the CC-chemokine receptor 5 gene influences perinatal transmission of human immunodeficiency virus type 1 to African-American infants |
| Q27693321 | Bioinformatic analysis of HIV-1 entry and pathogenesis |
| Q37463869 | C-C chemokine receptor type five (CCR5): An emerging target for the control of HIV infection. |
| Q36483857 | CCR5Delta32 59537-G/A promoter polymorphism is associated with low translational efficiency and the loss of CCR5Delta32 protective effects |
| Q33354082 | CCR5Delta32 genotypes in a German HIV-1 seroconverter cohort and report of HIV-1 infection in a CCR5Delta32 homozygous individual |
| Q41860559 | CCR5Delta32 protein expression and stability are critical for resistance to human immunodeficiency virus type 1 in vivo |
| Q33785473 | Chemokine coreceptor usage by diverse primary isolates of human immunodeficiency virus type 1 |
| Q33382126 | Chimeric SCID-hu Model as a Human Hematopoietic Stem Cell Host That Recapitulates the Effects of HIV-1 on Bone Marrow Progenitors in Infected Patients |
| Q81477463 | Clinical implications of discordant viral and immune outcomes following protease inhibitor containing antiretroviral therapy for HIV-infected children |
| Q37834099 | Coreceptor use in nonhuman primate models of HIV infection |
| Q44091684 | Counterpoint: Cord blood stem cell therapy for acquired immune deficiency syndrome. |
| Q38549079 | Cure for HIV: New possibility on horizon |
| Q92404447 | Cysteine-cysteine chemokine receptor 5 (CCR5) profile of HIV-infected subjects attending University of Calabar Teaching Hospital, Calabar, Southern Nigeria |
| Q27469707 | Definition of the stage of host cell genetic restriction of replication of human immunodeficiency virus type 1 in monocytes and monocyte-derived macrophages by using twins |
| Q33835337 | Donor- and ligand-dependent differences in C-C chemokine receptor 5 reexpression |
| Q39549670 | Effect of mutations in the second extracellular loop of CXCR4 on its utilization by human and feline immunodeficiency viruses. |
| Q24802476 | Establishment of a novel CCR5 and CXCR4 expressing CD4+ cell line which is highly sensitive to HIV and suitable for high-throughput evaluation of CCR5 and CXCR4 antagonists |
| Q96137182 | Ethical considerations of gene editing and genetic selection |
| Q34545588 | Genetic and functional analysis of R5X4 human immunodeficiency virus type 1 envelope glycoproteins derived from two individuals homozygous for the CCR5delta32 allele |
| Q36265627 | Genetic factors for aids progression: Analyses of HIV-1 resistant genes in India and therapeutic potentials of novel catalytic RNA and DNA molecules |
| Q37396102 | HIV-1 Nef responsiveness is determined by Env variable regions involved in trimer association and correlates with neutralization sensitivity |
| Q35995936 | Host factors influencing susceptibility to HIV infection and AIDS progression |
| Q36546894 | Human genetic polymorphisms affecting HIV-1 diseases |
| Q35020086 | Human immunodeficiency virus type 1 envelope-mediated neuronal death: uncoupling of viral replication and neurotoxicity |
| Q34169244 | Inhibiting HIV-1 infection in human T cells by lentiviral-mediated delivery of small interfering RNA against CCR5. |
| Q37596456 | Inhibition of human immunodeficiency virus replication by a dual CCR5/CXCR4 antagonist |
| Q35634983 | Loss of naïve cells accompanies memory CD4+ T-cell depletion during long-term progression to AIDS in Simian immunodeficiency virus-infected macaques. |
| Q34226885 | Macrophage-tropic simian/human immunodeficiency virus chimeras use CXCR4, not CCR5, for infections of rhesus macaque peripheral blood mononuclear cells and alveolar macrophages |
| Q37634319 | Maraviroc in the treatment of HIV infection. |
| Q89879093 | Metabolomics as an Approach to Characterise the Contrasting Roles of CCR5 in the Presence and Absence of Disease |
| Q36949816 | Mode of transmission affects the sensitivity of human immunodeficiency virus type 1 to restriction by rhesus TRIM5alpha |
| Q33855093 | Mucosal transmission and induction of simian AIDS by CCR5-specific simian/human immunodeficiency virus SHIV(SF162P3) |
| Q33854857 | No selection for CCR5 coreceptor usage during parenteral transmission of macrophagetropic syncytium-inducing human immunodeficiency virus type 1. |
| Q38182590 | Pathogenesis of HIV Infection |
| Q38631923 | Primary infection by a human immunodeficiency virus with atypical coreceptor tropism |
| Q36747765 | R5X4 viruses are evolutionary, functional, and antigenic intermediates in the pathway of a simian-human immunodeficiency virus coreceptor switch |
| Q24608200 | Role for CCR5Delta32 protein in resistance to R5, R5X4, and X4 human immunodeficiency virus type 1 in primary CD4+ cells |
| Q33648601 | Role of CXCR4 in cell-cell fusion and infection of monocyte-derived macrophages by primary human immunodeficiency virus type 1 (HIV-1) strains: two distinct mechanisms of HIV-1 dual tropism. |
| Q35018140 | Selective transmission of R5 HIV-1 variants: where is the gatekeeper? |
| Q39422249 | Sequencing the Biology of Entry: The Retroviral env Gene |
| Q37829631 | Stem cell-based approaches to treating HIV infection |
| Q29012920 | The biology of CCR5 and CXCR4 |
| Q22066237 | The coreceptor mutation CCR5Delta32 influences the dynamics of HIV epidemics and is selected for by HIV |
| Q37088591 | Topical application of entry inhibitors as "virustats" to prevent sexual transmission of HIV infection |
| Q46241929 | Transmission, Evolution, and Endogenization: Lessons Learned from Recent Retroviral Invasions |
| Q34823587 | Two mechanisms for human immunodeficiency virus type 1 inhibition by N-terminal modifications of RANTES |
| Q33785490 | Use of coreceptors other than CCR5 by non-syncytium-inducing adult and pediatric isolates of human immunodeficiency virus type 1 is rare in vitro |
| Q33808728 | Use of inhibitors to evaluate coreceptor usage by simian and simian/human immunodeficiency viruses and human immunodeficiency virus type 2 in primary cells |
| Q24524292 | Viral entry through CXCR4 is a pathogenic factor and therapeutic target in human immunodeficiency virus type 1 disease |
| Q33645423 | Will multiple coreceptors need to be targeted by inhibitors of human immunodeficiency virus type 1 entry? |
Search more.